Crawford ED - Search Results

1

Phase II evaluation of didemnin B in advanced adenocarcinoma of the kidney. A Southwest Oncology Group study.

Taylor SA, Goodman P, Crawford ED, Stuckey WJ, Stephens RL, Gaynor ER. Taylor SA, et al. Among authors: crawford ed. Invest New Drugs. 1992 Apr;10(1):55-6. doi: 10.1007/BF01275484. Invest New Drugs. 1992. PMID: 1607254 Clinical Trial.

2

Evaluation of menogaril in renal cell carcinoma. A Southwest Oncology Group phase II study (8504).

Stephens RL, Goodman P, Crawford ED, Spicer CF, Lowe BA, Ahmann FR, Chapman R, Natale RB. Stephens RL, et al. Among authors: crawford ed. Invest New Drugs. 1990;8 Suppl 1:S69-71. Invest New Drugs. 1990. PMID: 2143177 Free article.

3

High dose AZQ in renal cancer. A Southwest Oncology Group phase II study.

Stephens RL, Kirby R, Crawford ED, Bukowski R, Rivkin SE, O'Bryan RM. Stephens RL, et al. Among authors: crawford ed. Invest New Drugs. 1986;4(1):57-9. doi: 10.1007/BF00172018. Invest New Drugs. 1986. PMID: 3700042

4

Phase II trial of menogaril in metastatic adenocarcinoma of the prostate. A Southwest Oncology Group study.

Taylor SA, Blumenstein BA, Stephens RL, Crawford ED, Pistone B, Hill JB. Taylor SA, et al. Among authors: crawford ed. Invest New Drugs. 1994;12(1):67-70. doi: 10.1007/BF00873240. Invest New Drugs. 1994. PMID: 7960610 Clinical Trial.

5

Phase II trial of echinomycin for the treatment of advanced renal cell carcinoma. A Southwest Oncology Group study.

Marshall ME, Wolf MK, Crawford ED, Taylor S, Blumenstein B, Flanigan R, Meyers FJ, Hynes HE, Barlogie B, Eisenberger M. Marshall ME, et al. Among authors: crawford ed. Invest New Drugs. 1993 May-Aug;11(2-3):207-9. doi: 10.1007/BF00874157. Invest New Drugs. 1993. PMID: 8262733 Clinical Trial.

6

Phase II evaluation of amonafide in renal cell carcinoma. A Southwest Oncology Group study.

Higano CS, Goodman P, Craig JB, Kish JA, Rivkin SE, Wolf M, Crawford ED. Higano CS, et al. Among authors: crawford ed. Invest New Drugs. 1991 Nov;9(4):361-3. doi: 10.1007/BF00183582. Invest New Drugs. 1991. PMID: 1804814 Clinical Trial.

7

Phase II study of continuous infusion recombinant gamma interferon in renal carcinoma. A Southwest Oncology Group study.

Kuebler JP, Goodman PJ, Brown TD, Crawford ED, Reitz CL, Knight WA 3rd, Kish JA. Kuebler JP, et al. Among authors: crawford ed. Invest New Drugs. 1990 Aug;8(3):307-9. doi: 10.1007/BF00171843. Invest New Drugs. 1990. PMID: 2125585 Clinical Trial. No abstract available.

8

Phase II trial of high-dose intermittent interleukin-2 in metastatic renal cell carcinoma: a Southwest Oncology Group study.

Bukowski RM, Goodman P, Crawford ED, Sergi JS, Redman BG, Whitehead RP. Bukowski RM, et al. Among authors: crawford ed. J Natl Cancer Inst. 1990 Jan 17;82(2):143-6. doi: 10.1093/jnci/82.2.143. J Natl Cancer Inst. 1990. PMID: 2294224

9

Therapy for advanced renal cell cancer with spirogermanium: a Southwest Oncology Group Study.

Saiers JH, Slavik M, Stephens RL, Crawford ED. Saiers JH, et al. Among authors: crawford ed. Cancer Treat Rep. 1987 Feb;71(2):207-8. Cancer Treat Rep. 1987. PMID: 3802117 No abstract available.

10

Doxorubicin, mitomycin C and 5-fluorouracil in the treatment of hormone refractory adenocarcinoma of the prostate: a Southwest Oncology Group study.

Blumenstein B, Crawford ED, Saiers JH, Stephens RL, Rivkin SE, Coltman CA Jr. Blumenstein B, et al. Among authors: crawford ed. J Urol. 1993 Aug;150(2 Pt 1):411-3. doi: 10.1016/s0022-5347(17)35496-4. J Urol. 1993. PMID: 8326565 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

655 results

Search Page

Filters